Publikationen, an denen er mitarbeitet Aitor Uribarri (9)

2023

  1. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

2021

  1. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615

  2. COVID-19 and the impact of arterial hypertension—An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany)

    European Journal of Clinical Investigation, Vol. 51, Núm. 11

  3. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

    Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966

  4. Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: A subanalysis from the HOPE COVID-19 registry

    Emergency Medicine Journal, Vol. 38, Núm. 5, pp. 359-365

  5. Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases

    Archivos de Bronconeumologia, Vol. 57, pp. 13-20

  6. Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data

    Medicina Clinica, Vol. 157, Núm. 7, pp. 318-324

  7. Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score

    Frontiers in Medicine, Vol. 8

2020

  1. Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis

    Frontiers in Endocrinology, Vol. 11